1. Home
  2. MRVI vs CIVB Comparison

MRVI vs CIVB Comparison

Compare MRVI & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$3.55

Market Cap

472.8M

Sector

Health Care

ML Signal

N/A

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

N/A

Current Price

$22.37

Market Cap

500.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MRVI
CIVB
Founded
2014
1884
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
500.4M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
MRVI
CIVB
Price
$3.55
$22.37
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$4.57
$26.00
AVG Volume (30 Days)
1.1M
65.5K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
3.19%
EPS Growth
14.29
31.34
EPS
N/A
2.64
Revenue
$185,743,000.00
$19,023,000.00
Revenue This Year
$11.80
$15.24
Revenue Next Year
$7.74
$6.52
P/E Ratio
N/A
$11.02
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$17.47
52 Week High
$4.11
$25.59

Technical Indicators

Market Signals
Indicator
MRVI
CIVB
Relative Strength Index (RSI) 58.92 36.01
Support Level $3.65 $21.42
Resistance Level $3.65 $22.52
Average True Range (ATR) 0.18 0.71
MACD 0.06 -0.23
Stochastic Oscillator 74.66 16.46

Price Performance

Historical Comparison
MRVI
CIVB

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

Share on Social Networks: